Collegium Pharmaceutical has announced the publication of an analysis of the duration of effect of Xtampza ER (oxycodone extended-release capsules)...
Clinical results from a Phase III trial of Sufentanil NanoTab PCA System, from AcelRx Pharmaceuticals, for the treatment of moderate-to-severe...
FDA approves Senza II SCS for pain relief.
The sublingual sufentanil tablet system (SSTS) is a novel hand-held patient-controlled analgesia device developed for treatment of moderate-to-severe postoperative pain. Here we present the first results of its clinical use.
Scilex Pharmaceuticals received approval from the FDA for ZTlido (lidocaine topical system) 1.8% for the relief of pain associated with...
Flexion Therapeutics, Inc. announced an independent evaluation of clinical data for Zilretta
Nektar Therapeutics presented clinical data from the SUMMIT-07 Phase III study of NKTR 181, a first-in-class opioid analgesic to treat...
Results from a randomized controlled trial on the use of the Sinergy Cooled Radiofrequency System, from Kimberly-Clark Health Care, to...
Purpose: The Sleep Position Trainer (SPT) is a new option for treating patients with positional obstructive sleep apnea (POSA).
Background: Ulcerative colitis (UC) is a chronic inflammation of the colon characterised by periods of relapse and remission. It starts in the rectum and can extend throughout the colon. UC and Crohn's disease (CD) are the most common inflammatory bowel diseases (IBDs).